0001593968-20-001745.txt : 20200813 0001593968-20-001745.hdr.sgml : 20200813 20200813171942 ACCESSION NUMBER: 0001593968-20-001745 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller-Rich Nancy CENTRAL INDEX KEY: 0001735084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37841 FILM NUMBER: 201100302 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 10 HUDSON YARDS, 37TH FL CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kadmon Holdings, Inc. CENTRAL INDEX KEY: 0001557142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273576929 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-308-6000 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Kadmon Holdings, LLC DATE OF NAME CHANGE: 20120829 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2020-08-13 0001557142 Kadmon Holdings, Inc. KDMN 0001735084 Miller-Rich Nancy C/O KADMON HOLDINGS, INC. 450 E. 29TH STREET NEW YORK NY 10016 true false false false Stock Option (right to buy) 4.17 2020-08-13 4 A false 36364 4.17 A 2030-08-13 Common stock, $0.001 par value 36364 36364 D The option vests and becomes exercisable in three equal annual installments over 3 years from August 13, 2020, the date of grant. Only represents derivative securities of this class. /s/ Gregory S. Moss, Attorney-in-Fact 2020-08-13